WalletHub

Oblong Announces Letter of Intent to Merge with Dwellwell Analytics

Retrieved on: 
Martedì, Giugno 4, 2024

Oblong, Inc. (Nasdaq: OBLG) (“Oblong”), the award-winning maker of multi-stream collaboration solutions, announced today that it has signed a non-binding letter of intent (the “Letter of Intent”) with Dwellwell Analytics (“Dwellwell”), to acquire 100% of the outstanding equity interests of Dwellwell (the “Merger”).

Key Points: 
  • Oblong, Inc. (Nasdaq: OBLG) (“Oblong”), the award-winning maker of multi-stream collaboration solutions, announced today that it has signed a non-binding letter of intent (the “Letter of Intent”) with Dwellwell Analytics (“Dwellwell”), to acquire 100% of the outstanding equity interests of Dwellwell (the “Merger”).
  • This press release relates to a proposed transaction between Oblong, Inc., a Delaware corporation (“Oblong”), and Dwellwell Analytics, Inc., a Delaware corporation (“Dwellwell”) (the “proposed transaction”).
  • Neither Oblong nor Dwellwell gives any assurance that either Oblong or Dwellwell or the post-combination company will achieve its expected results.
  • Neither Oblong nor Dwellwell undertakes any duty to update these forward-looking statements, except as otherwise required by law.

Philip Morris International Tops Forbes’ 2024 Net Zero Leaders List

Retrieved on: 
Martedì, Giugno 4, 2024

Philip Morris International Inc. (PMI) (NYSE: PM) has ranked first in Forbes’ 2024 Net Zero Leaders ranking,1 which highlights the 100 U.S. public companies best positioned to reduce their greenhouse gas (GHG) emissions.

Key Points: 
  • Philip Morris International Inc. (PMI) (NYSE: PM) has ranked first in Forbes’ 2024 Net Zero Leaders ranking,1 which highlights the 100 U.S. public companies best positioned to reduce their greenhouse gas (GHG) emissions.
  • Forbes used data from firms Sustainalytics and Morningstar to rank companies’ commitment to a net zero future.
  • Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector.
  • PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties.

Videotron Ltd. Prices Private Offering of $600 Million Series 1 Senior Notes due 2029 and $400 Million Series 2 Senior Notes due 2034

Retrieved on: 
Sabato, Giugno 15, 2024

The Series 1 Notes will be sold at $999.47 per $1,000 principal amount of Series 1 Notes and the Series 2 Notes will be sold at $996.75 per $1,000 principal amount of Series 2 Notes.

Key Points: 
  • The Series 1 Notes will be sold at $999.47 per $1,000 principal amount of Series 1 Notes and the Series 2 Notes will be sold at $996.75 per $1,000 principal amount of Series 2 Notes.
  • The Offering is expected to close on or about June 21, 2024, subject to customary closing conditions.
  • "The great success of this transaction demonstrates the financial markets' trust in Videotron and marks a major step in reducing its borrowing costs," he added.
  • The Notes are being offered in Canada on a private placement basis in reliance upon exemptions from the prospectus requirements under applicable securities legislation.

Philip Morris International Presents at 2024 Deutsche Bank Global Consumer Conference

Retrieved on: 
Martedì, Giugno 4, 2024

Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector.

Key Points: 
  • Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector.
  • This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies.
  • In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands.
  • The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Equity LifeStyle Properties, Inc. Investors to Inquire About Securities Class Action Investigation – ELS

Retrieved on: 
Martedì, Giugno 4, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22421 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22421 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ELS LOSS ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Equity LifeStyle Properties, Inc. Investors to Inquire About Securities Class Action Investigation – ELS

Retrieved on: 
Venerdì, Maggio 31, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22421 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Retrieved on: 
Giovedì, Maggio 30, 2024

As previously reported in its SEC filings, Ocean Biomedical is delayed in filing the Form 10-Q as a result of previously disclosed developments with respect to filing of its 10-K for the year ended December 31, 2023.

Key Points: 
  • As previously reported in its SEC filings, Ocean Biomedical is delayed in filing the Form 10-Q as a result of previously disclosed developments with respect to filing of its 10-K for the year ended December 31, 2023.
  • The current notice will have no immediate effect on the listing or trading of Ocean Biomedical’s common stock on Nasdaq, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the company’s common stock.
  • Nasdaq indicated that the Company must: (i) no later than June 14, 2024, submit a plan to regain compliance with respect to the filing requirement; and (ii) on or before October 14, 2024, file the delinquent Form10-Q.
  • The Company intends to file the delinquent Form 10-Q as soon as practicable.

Faraday Future Receives Anticipated Letter from Nasdaq Regarding Form 10-Q

Retrieved on: 
Martedì, Maggio 28, 2024

Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced that on May 21, 2024, it received written notice from The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s failure to timely file the Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”) could serve as an additional basis for the delisting of the Company’s securities from Nasdaq under Nasdaq Listing Rule 5250(c)(1).

Key Points: 
  • Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced that on May 21, 2024, it received written notice from The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s failure to timely file the Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”) could serve as an additional basis for the delisting of the Company’s securities from Nasdaq under Nasdaq Listing Rule 5250(c)(1).
  • As previously disclosed, the Company requested a hearing before the Nasdaq Hearings Panel (the “Panel”), at which the Company will present its plan to file the Form 10-Q as well as its plan to remedy the stock price deficiency.
  • Although the Company’s request for a further stay remains outstanding with Nasdaq, the Company expects its securities to continue to trade on Nasdaq in the normal course during the pendency of the hearing process.

ROSEN, A LONGSTANDING LAW FIRM, Encourages Equity LifeStyle Properties, Inc. Investors to Inquire About Securities Class Action Investigation – ELS

Retrieved on: 
Domenica, Maggio 26, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22421 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22421 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Shapeways Receives Nasdaq Notice Regarding Late Filing of Quarterly Report on Form 10-Q

Retrieved on: 
Venerdì, Maggio 24, 2024

The Notice has no immediate effect on the listing or trading of the Company’s common stock or publicly traded warrants.

Key Points: 
  • The Notice has no immediate effect on the listing or trading of the Company’s common stock or publicly traded warrants.
  • The Notice provides that the Company has until July 22, 2024, to submit to Nasdaq a plan to regain compliance with the Rule.
  • If Nasdaq accepts the plan, Nasdaq may grant the Company an exception of up to 180 calendar days from the due date of the Form 10-Q, or until November 18, 2024, to regain compliance.
  • If that occurs, the Company may request a hearing before a Nasdaq Hearing Panel to review the determination.